litlas
Log inCreate account

Nader Rifai

Active 1986–2025

206
Papers
93,460
Citations
140
h-index
206
i10-index

Citations

Citations per year for Nader Rifai1945: 1 citations1964: 4 citations1976: 2 citations1987: 3 citations1988: 1 citations1989: 2 citations1991: 3 citations1992: 4 citations1993: 5 citations1994: 2 citations1995: 9 citations1996: 11 citations1997: 14 citations1998: 26 citations1999: 74 citations2000: 167 citations2001: 447 citations2002: 728 citations2003: 1,151 citations2004: 1,289 citations2005: 1,316 citations2006: 1,478 citations2007: 1,247 citations2008: 1,348 citations2009: 1,181 citations2010: 1,035 citations2011: 958 citations2012: 853 citations2013: 816 citations2014: 638 citations2015: 653 citations2016: 621 citations2017: 506 citations2018: 548 citations2019: 1,677 citations2020: 1,675 citations2021: 1,397 citations2022: 1,092 citations2023: 818 citations2024: 1,254 citations2025: 613 citations2026: 46 citations1946–1963: no citations, so these years are not shown1965–1975: no citations, so these years are not shown1977–1986: no citations, so these years are not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 8,117 citing papers, 28.9% of this breakdownUnited Kingdom: 2,125 citing papers, 7.6% of this breakdownChina: 1,420 citing papers, 5.1% of this breakdownItaly: 1,302 citing papers, 4.6% of this breakdownGermany: 1,262 citing papers, 4.5% of this breakdownCanada: 1,185 citing papers, 4.2% of this breakdownAustralia: 988 citing papers, 3.5% of this breakdownNetherlands: 968 citing papers, 3.5% of this breakdownSpain: 767 citing papers, 2.7% of this breakdownFrance: 756 citing papers, 2.7% of this breakdownJapan: 704 citing papers, 2.5% of this breakdownSweden: 650 citing papers, 2.3% of this breakdown
0%28.9%Other 27.9%

Institutions

Fields

  • Medicine70.7%
  • Biochemistry, Genetics and Molecular Biology9.9%
  • Immunology and Microbiology3.5%
  • Nursing3.1%
  • Neuroscience2.9%
  • Psychology2.3%
  • Other7.6%

Topics

  • Adipokines, Inflammation, and Metabolic Diseases5.8%
  • Lipoproteins and Cardiovascular Health4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.8%
  • Nutritional Studies and Diet2.3%
  • Atherosclerosis and Cardiovascular Diseases2.2%
  • Inflammatory Biomarkers in Disease Prognosis1.4%
  • Other80.5%

Coauthors

All papers

Open in search
  1. Markers of Inflammation and Cardiovascular Disease

    Authors: Thomas A. Pearson, George A. Mensah, R. Wayne Alexander, Jeffrey L. Anderson, Richard O. Cannon, Michael H Criqui, Yazid Y. Fadl, Stephen P. Fortmann, Yuling Hong, Gary L. Myers, Nader Rifai, Sidney C. Smith, Kathryn A. Taubert, Russell P. Tracy, Frank Vinicor - Circulation 2003 cited by 6,361

  2. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies

    Authors: Patrick M. Bossuyt, Johannes B. Reitsma, David E. Bruns, Constantine Gatsonis, Paul Glasziou, Les Irwig, Jeroen G. Lijmer, David Moher, Drummond Rennie, Henrica C. W. de Vet, Herbert Y. Kressel, Nader Rifai, Robert Golub, Douglas G. Altman, Lotty Hooft, Daniël A. Korevaar, Jérémie F. Cohen, For the STARD Group - Radiology 2015 cited by 1,305

  3. Developing a reporting guideline for artificial intelligence-centred diagnostic test accuracy studies: the STARD-AI protocol

    Authors: Viknesh Sounderajah, Hutan Ashrafian, Robert Golub, Shravya Shetty, Jeffrey De Fauw, Lotty Hooft, Karel G.M. Moons, Gary S. Collins, David Moher, Patrick M. Bossuyt, Ara Darzi, Alan Karthikesalingam, Alastair K. Denniston, Bilal A. Mateen, Daniel Shu Wei Ting, Darren Treanor, Dominic King, Felix Greaves, Jonathan Godwin, Jonathan Pearson‐Stuttard, Leanne Harling, Matthew D. F. McInnes, Nader Rifai, Nenad Tomašev, Pasha Normahani, Penny Whiting, Ravi Aggarwal, Sebastian J. Vollmer, Sheraz R. Markar, Trishan Panch, Xiaoxuan Liu - BMJ Open 2021 cited by 312

  4. C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

    Authors: Paul M. Ridker, Charles H. Hennekens, Julie E. Buring, Nader Rifai - New England Journal of Medicine 2000 cited by 5,857

  5. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies

    Authors: Patrick M. Bossuyt, Johannes B. Reitsma, David E. Bruns, Constantine Gatsonis, Paul Glasziou, Les Irwig, Jeroen G. Lijmer, David Moher, Drummond Rennie, Henrica C. W. de Vet, Herbert Y. Kressel, Nader Rifai, Robert Golub, Douglas G. Altman, Lotty Hooft, Daniël A. Korevaar, Jérémie F. Cohen - BMJ 2015 cited by 3,338

  6. Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women

    Authors: Paul M. Ridker, M. Vinayaga Moorthy, Nancy R. Cook, Nader Rifai, I‐Min Lee, Julie E. Buring - New England Journal of Medicine 2024 cited by 238

  7. Protein biomarker discovery and validation: the long and uncertain path to clinical utility

    Authors: Nader Rifai, Michael A. Gillette, Steven A. Carr - Nature Biotechnology 2006 cited by 1,845

  8. Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

    Authors: Paul M. Ridker, Nader Rifai, Lynda Rose, Julie E. Buring, Nancy R. Cook - New England Journal of Medicine 2002 cited by 3,608

  9. Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women

    Authors: Paul M. Ridker, Julie E. Buring, Nader Rifai, Nancy R. Cook - JAMA 2007 cited by 1,806

  10. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

    Authors: Børge G. Nordestgaard, Anne Langsted, Samia Mora, Genovefa Kolovou, H Baum, Éric Bruckert, Gerald F. Watts, Grażyna Sypniewska, Olov Wiklund, Jan Borén, M. John Chapman, Christa M. Cobbaert, Olivier Descamps, Arnold von Eckardstein, Pia R. Kamstrup, Kari Pulkki, Florian Kronenberg, Alan T. Remaley, Nader Rifai, Emilio Ros, Michel R. Langlois - European Heart Journal 2016 cited by 835

  11. Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

    Authors: Paul M. Ridker, Nader Rifai, Meir J. Stampfer, Charles H. Hennekens - Circulation 2000 cited by 2,431

  12. C-Reactive Protein Levels and Outcomes after Statin Therapy

    Authors: Paul M. Ridker, Christopher P. Cannon, David A. Morrow, Nader Rifai, Lynda M. Rose, Carolyn H. McCabe, Marc A. Pfeffer, Eugene Braunwald - New England Journal of Medicine 2005 cited by 2,297

  13. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis

    Authors: Eri Kato, David A. Morrow, Jianping Guo, David D. Berg, Michael A. Blazing, Erin A. Bohula, Marc P. Bonaca, Christopher P. Cannon, James A. de Lemos, Robert P. Giugliano, Petr Jarolı́m, Tibor Kempf, L. Kristin Newby, Michelle L. O’Donoghue, Marc A. Pfeffer, Nader Rifai, Stephen D. Wiviott, Kai C. Wollert, Eugene Braunwald, Marc S. Sabatine - European Heart Journal 2022 cited by 98

  14. Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk

    Authors: Hans K. Meier-Ewert, Paul M. Ridker, Nader Rifai, Meredith M. Regan, Nick J. Price, David F. Dinges, Janet Mullington - Journal of the American College of Cardiology 2004 cited by 1,199

  15. Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and Men

    Authors: Eric L. Ding, Yiqing Song, JoAnn E. Manson, David J. Hunter, Cathy C. Lee, Nader Rifai, Julie E. Buring, J. Michael Gaziano, Simin Liu - New England Journal of Medicine 2009 cited by 723

  16. Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy

    Authors: Paul M. Ridker, Nader Rifai, Jean MacFadyen, Robert J. Glynn, Lixia Jiao, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Jean‐Claude Tardif, Christie M. Ballantyne, R. Preston Mason, Deepak L. Bhatt - Circulation 2022 cited by 125

  17. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction

    Authors: Teresa T. Fung, Marjorie L. McCullough, P.K. Newby, JoAnn E. Manson, James B. Meigs, Nader Rifai, Walter C. Willett, Frank B. Hu - American Journal of Clinical Nutrition 2005 cited by 839

  18. Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial

    Authors: Paul M. Ridker, Lei Lei, Kausik K. Ray, Christie M. Ballantyne, Gary Bradwin, Nader Rifai - Journal of clinical lipidology 2023 cited by 66

  19. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events

    Authors: Paul M. Ridker, Julie E. Buring, Nancy R. Cook, Nader Rifai - Circulation 2003 cited by 2,291

  20. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

    Authors: Børge G. Nordestgaard, Michel R. Langlois, Anne Langsted, M. John Chapman, Kristin M. Aakre, H Baum, Jan Borén, Éric Bruckert, Alberico L. Catapano, Christa M. Cobbaert, Paul Collinson, Olivier Descamps, Christopher J. Duff, Arnold von Eckardstein, Angelika Hammerer‐Lercher, Pia R. Kamstrup, Genovefa Kolovou, Florian Kronenberg, Samia Mora, Kari Pulkki, Alan T. Remaley, Nader Rifai, Emilio Ros, Sanja Stanković, Ana Stavljenić-Rukavina, Grażyna Sypniewska, Gerald F. Watts, Olov Wiklund, Päivi Laitinen - Atherosclerosis 2019 cited by 238

  21. Effect of Statin Therapy on C-Reactive Protein Levels

    Authors: Michelle A. Albert, Ellie Danielson, Nader Rifai, Paul M. Ridker, for the PRINCE Investigators - JAMA 2001 cited by 1,654

  22. Lipoprotein(a) and Risk of Type 2 Diabetes

    Authors: Samia Mora, Pia R. Kamstrup, Nader Rifai, Børge G. Nordestgaard, Julie E. Buring, Paul M. Ridker - Clinical Chemistry 2010 cited by 240

  23. Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial

    Authors: Paul M. Ridker, Jean MacFadyen, Robert J. Glynn, Gary Bradwin, Ahmed Hasan, Nader Rifai - European Heart Journal 2020 cited by 154

  24. Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women

    Authors: Sandeep Bansal, Julie E. Buring, Nader Rifai, Samia Mora, Frank M. Sacks, Paul M. Ridker - JAMA 2007 cited by 1,627